1. Rafiee-Tehrani, M. and Mehramizi, A., In-vitro release studies of piroxicam from oil-in-water creams and hydroalcoholic gel topical formulation, Drug Dev. Ind. Pharm., 2000, vol. 26, no. 4, p. 409.
2. Payne, R., Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain, Semin. Oncol., 1998, vol. 25, no. 3, suppl. 7, p. 47.
3. Knutson, K., Krill, S., Lambert, W., and Higuchi, W., Physicochemical aspects of transdermal permeation, J. Contr. Rel., 1987, vol. 6, no. 1, p. 59.
4. Bucher, U. and Sanger, A., Diclofenac emulgel in the treatment of localized rheumatic disorders, Proc. 16th Int. Congr. on Rheumatology (IL: AR), Sydney, 1985.
5. Janbroers, J., Review of the toxicology, pharmacodynamics and pharmacokinetics of thiocolchicoside, a GABA-agonist muscle relaxant with antinflammatory and analgesic action, Acta Ther., 1987, vol. 13, p. 221.